The right diagnosis,
right away,
at the right price.

We are the creators of Genomtec ID, a mobile platform for genetic diagnostics at the point of patient care. We have just obtained our CE-IVD Mark for the GenomtecID Respiratory Panel 5-Plex (RP5-PLEX) which detects viruses and bacteria causing respiratory tract infections, the only solution of this kind in Europe. See more >>



Genomtec at BIO International Convention

We are pleased to announce that Genomtec team (Miron Tokarski & Charudutt Shah) will attend BIO 2023 from Jun 5-8, 2023 in Boston. We’re excited to meet with likeminded companies that have an interest in advancing diagnostics and enable more point of care diagnostics. We are looking forward to exploring strategic opportunities. Find our company […]


Interview with Miron Tokarski, CEO of Genomtec S.A. at Gazeta Giełdy i Inwestorów „Parkiet”

Key interview subjects: – Funds raised from the share issue will impact the realization of milestones and increase the value of Genomtec’s technology – M&A process update – New project in the area of oncology  


Genomtec S.A. will raise PLN 13.1 million from share issue

Funds will increase the value of the Company’s technology in M&A transaction. More informtaion: